Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Randomized Trial of IVIg With or Without Cyclophosphamide in Pemphigus

NCT00483119 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT00483119
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00483119 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Randomized Trial of IVIg With or Without Cyclophosphamide in Pemphigus
Lead sponsor
NYU Langone Health
Phase
Phase 2
Overall status
Terminated
Start date
April 30, 2007
Completion date
February 28, 2011
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pemphigus vulgaris